Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…

May 30, 2011 |  

M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins as Chief Operating Officer, and Simon Walker who takes on a Business Director role. This news comes as M3 Inc. releases its 2016 full-year results, with year-on-year revenue growing by 21%, and continued strong growth in key markets across Europe, US, Japan, China, Korea and India, and with membership of M3’s 100% verified physician communities now at over 4 million members.

Paul Rice has been appointed as Chief Operating Officer for M3’s rapidly expanding operations in Europe. Paul will lead the further development of M3’s services and the next phase of the company’s rapid growth in Europe. He brings more than 25 years of industry experience which includes senior roles at Merck and Walgreens Boots Alliance.Dr Tim Ringrose, CEO of M3 EU Ltd, commented “M3’s capabilities are becoming firmly established in key European markets and I’m delighted to welcome Paul to M3 as we continue to drive M3’s growth in key markets and expand the services we provide to healthcare”.

Simon Walker joins M3 (EU) as a Business Director, working across M3’s portfolio of promotional and medical education solutions in the UK and globally. Having initially trained as a journalist, Simon has had a successful career in medical publishing. After twenty years with BMJ (British Medical Journal), he set up a consultancy, TallSim Limited and has worked with organisations such as Kanga Healthcare and RCNi. He is also a committee member of Pharmaceutical Marketing Society.

About M3: M3 operates in Asia, the US and Europe with more than 4 million physician doctor members globally via M3.com, MDLinx, Medigate, M3 Medical and Doctors.net.uk. 5th on Forbes’ Most Innovative Growth Companies 2016, M3 provides pharmaceutical marketing, research services and career placement services for physicians.

For more information on the acquisition of Rotamaster by M3 please contact Hannah Brown on +44 (0)7747 273879 or hannah.brown@eu.m3.com. For more information on M3 visit http://eu.m3.com/

This content was provided by M3 (EU)

Company Details

- PMLiVE

M3 (EU)

Email
Website

 Latest Content from  M3 (EU) 

Tailored and Targeted Pharmaceutical Marketing

Learn more about targeted personas for HCP marketing.    If pharma companies want to differentiate themselves against their competition and produce impactful results they must be much bolder than the current state...

Learning to invest in doctors’ education

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for...

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

How do doctors spend their time online?

In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.

How do doctors want to engage with pharma on new products?

More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of treatment and how do they...

M3 Acquires MirVracha LCC in Russia Launching Full-Scale Development of Physician Platform Business in Russia

M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; URL: https://corporate.m3.com/; “M3” below) has announced the acquisition of MirVracha LCC (Headquarters: Moscow, Russia; CEO: Shotaro Yamamoto; “MirVracha” below), a website provider...

Revolutionising the Digital Content Delivery Model

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver...

Healthcare in the Digital Age

Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs...

UK's department of Health deploys information campaign to ensure continued vigilance over Ebola

The threat of Ebola being transmitted within the UK may be low but frontline health workers must remain vigilant nevertheless. This is the message being communicated by the Department of...